X-7105818-C-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_012080.5(PUDP):āc.82G>Cā(p.Val28Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000142 in 1,195,738 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 8 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_012080.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PUDP | NM_012080.5 | c.82G>C | p.Val28Leu | missense_variant | 2/4 | ENST00000381077.10 | NP_036212.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PUDP | ENST00000381077.10 | c.82G>C | p.Val28Leu | missense_variant | 2/4 | 1 | NM_012080.5 | ENSP00000370467 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000269 AC: 3AN: 111366Hom.: 0 Cov.: 23 AF XY: 0.0000894 AC XY: 3AN XY: 33560
GnomAD3 exomes AF: 0.0000345 AC: 6AN: 174033Hom.: 0 AF XY: 0.0000331 AC XY: 2AN XY: 60493
GnomAD4 exome AF: 0.0000129 AC: 14AN: 1084372Hom.: 0 Cov.: 29 AF XY: 0.0000143 AC XY: 5AN XY: 350290
GnomAD4 genome AF: 0.0000269 AC: 3AN: 111366Hom.: 0 Cov.: 23 AF XY: 0.0000894 AC XY: 3AN XY: 33560
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2023 | The c.151G>C (p.V51L) alteration is located in exon 3 (coding exon 3) of the PUDP gene. This alteration results from a G to C substitution at nucleotide position 151, causing the valine (V) at amino acid position 51 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at